Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients

Br J Haematol. 2012 Oct;159(1):111-3. doi: 10.1111/j.1365-2141.2012.09233.x. Epub 2012 Jul 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / administration & dosage*
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Antiviral Agents / administration & dosage
  • Boronic Acids / administration & dosage
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Dose-Response Relationship, Drug
  • Female
  • Herpes Zoster / chemically induced*
  • Herpes Zoster / drug therapy
  • Herpes Zoster / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / virology*
  • Pyrazines / administration & dosage
  • Pyrazines / adverse effects*
  • Retrospective Studies

Substances

  • Antiviral Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Acyclovir